FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

57911000001109: Ranclav 625mg tablets (Ranbaxy (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16343101000001117 Ranclav 625mg tablets (Ranbaxy (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16343201000001112 Ranclav 625mg tablets (Ranbaxy (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Is a Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Is a Co-amoxiclav 500mg/125mg tablets true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Is a Co-amoxiclav 500mg/125mg tablets false Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Is a Ranclav true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) 21 tablet 3 x 7 tablets Is pack of False Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier
Ranclav 625mg tablets (Ranbaxy (UK) Ltd) 21 tablet 3 x 7 tablets Has AMP True Ranclav 625mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start